Despite the numerous advances made in breast cancer research, carcinoma of the breast is still the most common, disfiguring and deadliest cancer among women[@b1]. Screening for breast cancer has led to earlier detection; however, the age old dilemma of "watch-and-wait" or to aggressively treat breast lesions haunt clinicians[@b1][@b2]. The understanding of BRCA1 and BRCA2 gene mutations has saved lives, but these findings account for only 5 to 10% of breast cancer cases[@b1]. Additional paradigms, i.e. biological models, may be needed in order to increase early detection and treatment efficacy[@b1][@b2].

Biological models, such as those for breast cancer, simulate the simultaneous operations and interactions of multiple processes and molecular networks, in an attempt to re-create and predict the appearance of complex phenomena such as breast cancer progression[@b3]. A model that can reflect the presence and progression of malignancy among women would enhance our knowledge of breast cancer, and serve as an enabling system for biomarker discovery and credentialing of candidate markers so that the biological causality of any analyte(s) can be assessed. With respect to the study of breast cancer, there are currently three major methods for creating models for studying breast cancer progression. The three methods utilize either breast cancer tumor cell lines (BCTCL), xenografts of cell lines, and the third method uses animals -- in this case genetically engineered mice for creating various models for studying breast cancer[@b1]. All three models have generated useful insight into cancer progression; however, despite their utility no individual model recapitulates all aspects of cancer progression[@b4].

In the case of BCTCL research, the main question is - are the cell lines representative of human breast cancer and how well do they capture breast cancer tumorigenesis in the context of the unique tumor-stroma microenvironment? This question is debatable with strong evidence supporting both sides of the discussion. The fact is that no single cell line is representative of the disease process. To date, there are 51 BCTCL used to detect genetic abnormalities associated with breast cancer. However, the major concern is that multiple variants of the same cell line may exist and display distinct phenotypes. This suggests that they have acquired genetic changes that might preclude comparison between different studies[@b1][@b2][@b3]. Moreover, the ability of *ex vivo* cell line experiments to recapitulate the tumor microenvironment is in question, with stoma and extracellular matrix interactions, immune cell involvement, vasculature, and the complex milieu of the blood itself all contributing to the tumor cell biology. Additionally, cell lines are prone to genotypic and phenotypic drift during their continual culture and there is always the problem of contamination[@b1][@b2][@b3][@b4].

Xenografts models are also very useful in studying breast cancer and have certainly helped understand genetic pathways associated with breast cancers but they are also problematic. Many of the problems that plague cell line studies also affect xenograft-driven modeling; however, a major problem is that xenografts must be established in immunocompromised mice[@b4][@b5][@b6]. The absence of an intact immune system may profoundly affect tumor development and progression as this microenvironment is entirely artificial. In fact, there is increasing evidence of roles for the immune system in both early stage breast cancer and metastasis[@b1][@b4][@b5][@b6][@b7]. There are also stoma differences between mouse and human breast tissues the must be taken into account. However, the major problem with xenograft models has to deal with breast cancer metastasis because metastatic cells preferentially colonize the lungs in mice, (instead of developing brain and liver metastasis) contain less fibrosis and inflammation then human tumors, nearly all are hormone independent as opposed to approximately half of human breast cancers that are hormone dependent, Another major draw-back is the lack of histological concordance between tumors from genetically engineered mice and the common types of human breast cancers. Finally, most tumors from mice do not resemble the most common subtypes of breast cancer. Taken together, clinicians and researchers may benefit by having an additional model system for assessing breast cancer tumorigenesis and in particular a predictive model for treatment response[@b4].

One question emanating from the aforementioned paragraphs is what is the alternative to those models? The answer we are proposing is the use of the salivary proteome to study and assess cancer progression. The basic secretory units of the salivary glands are phenotypically similar to those of the mammary glands[@b8][@b9][@b10][@b11][@b12]. With the submandibular gland being the exception; they both have origins from the ectodermal germ layer. Both tissues are compound exocrine glands composed of specialized glandular epithelia. The tissues are characterized with two epithelial cell types i.e., ductal and acinar cells along with myoepithelial cells which contract to move fluid from the acinar lumen to the ducts. The ductal epithelial cells (terminal ducts) adjacent to the acinar units are cuboidal[@b8][@b9][@b10][@b11][@b12].

From an immunohistological perspective there are a number of similarities between the mammary and salivary gland tissues. Both tissues have HER2/neu receptors on their ductal epithelial cells which can be overexpressed in malignant transformation[@b8][@b9][@b10][@b11][@b12]. Additionally, epithelial cells of both tissues have estrogen, progesterone, and androgen receptors that can be overexpressed[@b8][@b9][@b10][@b11][@b12]. p53 tumor suppressor gene is often mutated with overexpression of ineffective, mutated protein in carcinomas of the breast or the salivary glands. More interesting is that these proteins can be found in mammary ductal fluids and saliva[@b8][@b9][@b10][@b11][@b12]. As a consequence, the purpose of this manuscript is to provide evidence for the use of salivary protein profiles as an *in vivo* adjunct model for studying breast cancer progression.

Results and Discussions
=======================

The results of the proteomic analysis yielded 233 proteins that were either up or down regulated secondary to the presence of carcinoma of the breast. The 233 proteins represent 46% of the total number of proteins (505) identified among normal individuals assayed in this report. [Table 1](#t1){ref-type="table"} lists the 233 proteins. Of the 233 proteins, 142 were up-regulated and 91 were down regulated. The down regulated proteins are emboldened in [Table 1](#t1){ref-type="table"}. In addition, the profile consists of both high and low abundant salivary proteins assayed by both mass spectrometry and enzyme-linked immunosorbent assay (ELISA) respectively.

In order to compare the results to published proteomic cancer cell analysis, the proteins were categorized into ten groups of cellular activity[@b13][@b14]. The groups are illustrated in [Fig. 1](#f1){ref-type="fig"} and are as follows: 1) Genomic proteins; 2) molecular chaperones; 3) cell growth; 4) apoptotic proteins; 5) anti-inflammatory and immunoresponse proteins; 6) cytoskeletal proteins; 7) metabolic proteins; 8) membrane associated proteins and 9) antimicrobial proteins[@b13][@b14].

As illustrated in [Fig. 1](#f1){ref-type="fig"} and [Table 1](#t1){ref-type="table"}, the metabolic protein category reflected 24% of the 236 proteins while the inflammatory/immunoresponse and the cytoskeletal categories exhibited 23% and 17% of the total number of proteins respectively. Eighty four (36%) of the proteins were detected in the early stage carcinomas (Stage 0 & Stage I).

[Table 2](#t2){ref-type="table"} demonstrates how each protein was assayed and which proteins were present in varying cancer cell lines cited in the literature[@b15][@b16][@b17][@b18]. Fifty one of the 233 proteins (22%) could be identified in the SKBR3 cell line, 34 (14%) in the MCF7, 4 (2%) in the T47D, 29 (12%) in the MB-MDA-231, 26 (11%) in the 8701-BC and 43 (18%) in malignant tumor tissues. Twenty four (11%) were common to three or more of the cell lines.

Additionally, information is provided as to which proteins are contain within both salivary and breast tissue exosomes. Seventy one (30%) proteins from the panel were found to be contained within salivary exosomes and 35 (15%) proteins were within breast cancer tissue exosomes. There were twenty seven (11%) proteins that were common to both the salivary and the breast tissue exosomes.

[Table 3](#t3){ref-type="table"} displays the results from the GO and AmiGO analyses. It illustrates the overlapping functional diversity of the panel with respect to their associated molecular processes.

[Table 4](#t4){ref-type="table"} represents a sampling of some of the significant pathways calculated by the National Cancer Institute's Pathway Interaction Database. The signaling events mediated by HDAC Class III was highly significant at the p \< 0.01 × 10^−16^ level as was the glucocorticoid receptor regulatory network at the p \< 0.01 × 10^−6^ level.

The analyses for nodal & Her2/neu receptor status were also performed and published prior to this manuscript[@b10][@b11]. Briefly, the results yielded approximately 174 differentially expressed proteins in the saliva specimens lymph node status. There were 55 proteins that were common to both cancer stages in comparison to each other and healthy controls. In contrast, there were there were 20 proteins unique to Stage IIa and 28 proteins that were unique to Stage IIb[@b10]. The results Her2/neu receptor status yielded approximately 71 differentially expressed proteins in the saliva specimens. There were 34 up-regulated proteins and 37 down regulated proteins[@b11].

The results of the Harvard Partners Center for Genetics and Genomics, Cambridge, MA., proteomic analyses confirmed our findings and provided us with additional markers for this manuscript[@b12].

The ensuing paragraphs further detail each protein category and how the proteins of each category relate to *carcinogenesis of the breast*.

Genomic Integrity Related Proteins (10, 4%)
-------------------------------------------

Ten salivary proteins related to genomic integrity were found to be variant (over-expressed) in the presence of carcinoma of the breast. Eight of the ten proteins were histones while the remaining two proteins were associated with genomic maintenance. Of the two aforementioned proteins, the TLS oncogene maintains genomic integrity and mRNA/microRNA processing, while the other protein, Proliferating Cell Nuclear Antigen, is implicated with DNA repair. Both proteins are involved in breast cancer progression[@b19][@b20].

The remaining eight belong to the histone family of proteins. Histones are a group of basic proteins that are involved with nuclear DNA and help condense it into chromatin[@b21]. Histones are basic proteins, and their positive charges allow them to associate with DNA, which is negatively charged. Some histones function as molecular reels for the thread-like DNA to wrap around. Each histone octamer is composed of two copies each of the histone proteins H2A, H2B, H3, and H4. The chain of nucleosomes is then wrapped into a 30 nm spiral called a solenoid, where additional H1 histone proteins are associated with each nucleosome to maintain the chromosome structure[@b19][@b20][@b21][@b22][@b23][@b24][@b25].

Of particular interest within the group of histones is the H2A family. This group in particular is epigenetically associated with carcinoma of the breast[@b26]. The H2AX variant for example ([Table 1](#t1){ref-type="table"}), functions as a sensor of DNA damage and responds by defining the cellular response for DNA repair or apoptosis. It is also an indicator of tumor radio-sensitivity and is associated with BRCA1 and E-Cahedrin1 activity. E-Cahedrin1 was found to be down regulated in saliva[@b25][@b26][@b27].

Histone 3.2 is also present in saliva in the protein profile and is associated with invasive ductal cell carcinoma[@b28]. It is routinely used in tumor cell immunohistochemistry to determine the grade of the tumor. The presence of the over-expressed H3, H2AX and p300 proteins may possibly explain the upregulated presence of p21^(Waf−1)^ and CA 15-3 in saliva[@b29].

Molecular Chaperones/Heat Shock proteins (14, 6%)
-------------------------------------------------

Heat shock proteins (HSPs), also referred to as stress proteins, are a group of cellular proteins that respond to extreme temperature changes, infection, inflammation and oxygen deprivation. The proteins function as molecular chaperones and assist in the folding and maintenance of newly translated proteins, the refolding of denatured proteins and the further unfolding of misfolded or destabilized proteins to assist in their degradation[@b30]. Alterations in HSP expression may also increase due to other sources of cellular stress, including osmotic stress and the unfolded protein response, mediated by the ATF family of transcription factors. HSP expression and function can be deregulated during pathophysiological processes such as breast carcinogenesis[@b30].

[Table 1](#t1){ref-type="table"} exhibit fourteen proteins that function as molecular chaperones. Included among these are the overexpressed proteins Hsp27, Hsp40 and Hsp70. Hsp70 is especially important as this chaperone can block the programmed cell death that often accompanies malignant transformation. Additionally, Hsp70 may be involved in mitotic spindle formation and cell proliferation[@b31].

In addition to the heat shock proteins, there were a number of proteins associated with protein folding and the catalyzation of --S--S-- bonds. Of importance is the protein disulfide isomerase (PDI), which has shown to be upregulated in breast cancer tissues[@b30][@b31].

Growth Factors and Their Receptors (19, 7%)
-------------------------------------------

Growth factors are polypeptides that stimulate cell proliferation by binding to membrane receptors; EGF for example has been cited as a salivary protein for nearly four decades and is recognized as being up-regulated in the presence of carcinoma of the breast along with the solubilized receptors EGFR1 and Her2/neu[@b32][@b33]. TGFα, another ligand of the EGF/Her2 signaling pathway, was found to over-expressed. Within the EGF/Her2 signaling pathway, the following downstream proteins were overexpressed: AKT1, CALM, CDH1, CALM3, EGF, EGFR, GRB2, MUC1, PAX, RAC1, STAT1, and UB[@b34].

VEGF, a growth factor implicated in angiogenesis was also upregulated as were its associated downstream proteins AKT1, FGF2, FYN, NOS1, NOS3, p21, TNFα and VAV3[@b35].

Apoptotic Related Proteins (13, 5%)
-----------------------------------

There were thirteen proteins related to apoptosis that are presented in [Table 1](#t1){ref-type="table"}. Among the thirteen proteins there were five prominent proteins of the intrinsic apoptotic pathway: p53, Apaf-1, 14-3-3δ, Xiap and p21^WAF−1^. p53 and Apaf-1 were down regulated while14-3-3δ, Xiap and p21^WAF−1^ were up-regulated. This pattern appears to be consistent with cancer progression as cellular proliferation is one the hallmarks of this disease[@b36]. For example XIAP is a protein that impedes apoptotic cell death. XIAP is a member of the inhibitor of apoptosis family of proteins and is the most potent human IAP protein currently identified. In addition, there is the up-regulation of 14-3-3δ among this group of proteins. 14-3-3δ is a p53 inhibitor via Mdm2 inactivation. Additionally, when bound to KRT17, it regulates protein synthesis and cell growth by stimulating the Akt/mTOR pathway[@b36][@b37][@b38].

Finally, the up-regulated presence of the p21^WAF−1^ protein suggests a possible anti-apoptotic role by suppressing pro-apoptotic genes. Phosphorylated p21^WAF1^ expression, for example in breast cancer, may be associated with an inability of p21^WAF1^ to inhibit cell cycle progression[@b38][@b39][@b40]. Additionally, p21^WAF1^, when phosphorylated via PI3K pathway may bind with PCNA and facilitate the inactivation of capase-3 which is essential in the apoptotic process. It can also bind with PCNA inhibiting DNA repair. The p21^WAF1^ may also be unable to regulate Cdc25C binding with PCNA which is necessary for cell cycle arrest the G~2~/M checkpoint[@b41][@b42]. Collectively, the aforementioned panel of proteins may have utility in assessing anti-apoptotic activity in cancer progression[@b36][@b37][@b38][@b39][@b40][@b41][@b42][@b43].

Chronic Inflammatory/Immunoresponse Proteins (53, 23%)
------------------------------------------------------

Fifty three (23%) of the salivary proteins identified in [Table 1](#t1){ref-type="table"} were associated with the presence of a Chronic Inflammatory Response. Of the 53 proteins of this group, 10 (19%) were Th1/Th2 cytokines. The presence of VEGF, IL-10 and IL-6 may be a consequence of mutations in the serine/threonine-protein kinase B-Raf pathway (BRAF)[@b44][@b45]. Additionally, mutations in the BRAF oncogene also promotes the secretion of IL-1β, an innate inflammatory cytokine mediator which can drive neoplastic cells to up-regulate molecules that inhibit the function of anti-tumor lymphocytes. This may also be the reason for increased salivary presence of IL-1RA among cancer patients[@b44][@b45].

Additionally, AKT1, CDKN1A, IFNγ, IL4, IL6, IL8, KRT14, KRT17, KRT5, SFN, STAT1 and p53 are associated with numerous overlapping pro-inflammatory, immunological pathways such as the glucocorticoid receptor regulatory network (GR) and the IFN-γ/Stat1 pathway[@b44][@b45][@b46][@b47]. The activated GR complex up-regulates the expression of anti-inflammatory proteins in the nucleus or represses the expression of pro-inflammatory proteins in the cytosol by preventing the translocation of other transcription factors from the cytosol into the nucleus. This coupled with the up-regulated activities of the IFN-γ/Stat1 pathway and the increase concentrations of TNF-α and IFN-γ may be significant as this suggests possible T cell exhaustion from constant exposure to tumor antigens or the absence of the HLA-A2 allele[@b44][@b45][@b46][@b47].

Cytoskeletal (40, 17%)
----------------------

The cytoskeleton is present in all eukaryotic cells and provides the cell with structure, shape, mobility and by excluding macromolecules from some of the cytosol. It is also involved in cell migration and is believed to be involved in tumor dissemination[@b48]. Cytoskeleton protein complexes are also important regulators of migration, angiogenesis, cell polarity, cell morphology, intracellular trafficking and signal transduction. Many cytoskeleton proteins associated with cancer and are currently being used as histopathological biomarkers[@b48][@b49][@b50].

The most abundant group in [Table 1](#t1){ref-type="table"} is the cytokeratins. There are 16 cytokeratins among the cytoskeletal proteins. Nine of the cytokeratins are acidic Type 1 cytokeratins while seven are neutral Type II cytokeratins. The wide range of cytokeratin expression may result from the different types of salivary tissues contributing to the composition of whole saliva i.d., serous, mixed and mucinous secretions. However, similar to salivary gland ducts, normal breast ducts contain at least 3 types of epithelial cells: luminal (glandular) cells, basal/myoepithelial cells and stem cells[@b50]. Myoepithelial and luminal epithelia can be distinguished by their different cytokeratin expression patterns. Myoepithelial cells typically express cytokeratin 5/6 and cytokeratin 17, while luminal cells typically express cytokeratins 8 and 18. A small fraction of breast cancers express CK5 together with its major partners CK14 and CK17. Of particular interest is the presence of Cytokeratins 5, 14 and 17 as they are generally associated with poor prognosis and short disease-free survival[@b48][@b49][@b50][@b51].

Within the salivary group of cytoskeletal proteins, of particular interest, are the proteins E-cadherin, γ-catenin, gesolin and vimentin which were down regulated in saliva. Together, these proteins are associated with the noncanonical planar cell polarity pathway which regulates the cytoskeleton that is responsible for the shape of the cell. E-cadherin to regulate b-catenin signaling in the canonical Wnt pathway; its potential to inhibit mitogenic signaling through growth factor receptors and the possible links between cadherins and the molecular determinants of epithelial polarity[@b52][@b53]. Each of these potential mechanisms provides insights into the complexity that is likely responsible for the tumor-suppressive action of E-cadherin[@b52][@b53].

Metabolic Proteins (56, 24%)
----------------------------

The metabolic proteins represent the largest of the nine categories of salivary proteins that were changed as a consequence of the presence of breast cancer. [Table 1](#t1){ref-type="table"} shows that the 56 metabolic protein composed of 20 enzymes, 10 enzyme inhibitors, 10 transport proteins, 4 detoxification and redox proteins and 14 proteins of miscellaneous metabolic functions.

One interesting fact concerning the array of metabolic proteins is that alpha enolase, glucose-6-phosphate isomerase, fructose biphosphate aldolase, malate dehydrogenase, phosphoglycerate kinase 1, and triophosphate isomerase, are all associated with the glycolytic anaerobic pathway[@b54][@b55][@b56][@b57][@b58][@b59]. However, it is the presence of pyruvate kinase (PKM2) which suggests the occurrence of the Warburg effect[@b54][@b55]. The Warburg effect, suggested by Otto Warburg in 1927, suggests that among cancer cells there is a shift from ATP generation through oxidative phosphorylation to ATP generation through glycolysis even in the presence of normal oxygen concentrations[@b54][@b55][@b56][@b57][@b58][@b59][@b60]. The presence of the PKM2 protein suggests the occurrence of a glycolytic shift which is the metabolic hallmark of proliferating cells[@b54][@b55][@b56][@b57][@b58][@b59][@b60][@b61][@b62].

A pathway analysis was performed on the list of these proteins and it revealed that ALDOA, ENOA, PGK1 and PKM2 are members of the Hypoxia-Inducible transcription Factor-1 alpha network (HIF-1α). The HIF-1α pathway deregulation can produce consequences in disease settings with a chronic inflammatory component. It has also been shown that chronic inflammation is self-perpetuating and that it distorts the microenvironment as a result of aberrantly active transcription factors. As a consequence, alterations in growth factor, chemokine, cytokine, and ROS balance occur within the cellular milieu that in turn provide the axis of growth and survival needed for *de novo* development of cancer and metastasis. It promotes angiogenesis and is consistent with the hypoxic events associated with the Warburg effect[@b54][@b55][@b56][@b57][@b58][@b59][@b60][@b61][@b62][@b63].

Membrane and Calcium Binding Related Proteins (18, 7%)
------------------------------------------------------

The most numerous proteins within this category are the annexins and the S100 family of proteins. The annexins are a large family of proteins which can be both intra and extracellular in presence having a wide variety of physiological functions[@b64]. They can be associated with membrane scaffolding, which is relevant to changes in the cell's shape and have been shown to be involved in trafficking and organization of vesicles exocytosis. They are also associated with calcium ion channel formation. More importantly, annexins are associated with inflammation and apoptosis. With respect to carcinoma of the breast, the over expression of ANXA1, ANXA2, ANXA3 have been implicated with this malignancy[@b64][@b65][@b66]. ANXA1, expression, for example, was significantly *associated with* disease progression and metastases. ANXA2 and ANXA3 have also been related to poor prognosis and may have potential as prognostic indicators[@b67][@b68].

S100 proteins, similar to the annexins, are implicated in a wide variety of intracellular and extracellular functions. For example, they are involved in regulation of protein phosphorylation, transcription factors, cytoskeleton dynamics, cell growth/differentiation, and the inflammatory response[@b69][@b70][@b71][@b72].

A comprehensive study concerning the relationship between S100 proteins and breast cancer was conducted by Cancemi *et al*. in 2010[@b72]. The study identified the up-regulation of S100 protein expression in breast cancer tissues. Specifically, they observed S100A2, S100A4, S100A6, S100A7, S100A8, S10011 and S10013 as being disparate in the presence of breast cancer. Similarly, the proteins S100A4, S100A6, S100A7, S100A8 and S10011 were over expressed in saliva[@b72].

Anti-Microbial Proteins (14, 6%)
--------------------------------

[Table 1](#t1){ref-type="table"} illustrates 14 proteins that were not similar due to the presence of carcinoma of the breast. As illustrated, there are three mucins, which in health protect the integrity of the epithelia provide a barrier against microbial invasion. The balance of the panel consists of proline-rich proteins, lysozymes and histatins which have been documented in the dental literature as having antibacterial properties[@b73][@b74].

The reason for their alteration in expression is unknown and may be due to changes in the oral microbiota[@b75][@b76]. As to whether the oral microbiome was altered as a consequence of tumor development or was an etiological cause for tumorigenesis to begin with, is also unknown. Our microbiota might be considered unknown variable at present, but they are likely to become more familiar considering the accelerated pace of research in this area[@b75][@b76][@b77][@b78].

Study Limitations
-----------------

The manuscript presents a "proof of concept", but has its limitations. Further study is required to address the phenotypic diversity breast cancer tumors. Tumors that are of different histological types, pathological grade and molecular subtypes should be proteomically assessed. Late stage tumors should also be studied and proteomically characterized according to the metastatic site of the tumor. High-throughput analysis is necessary in order to assay numerous individual specimens, where pooled specimens were used here to limit expense. The final task would be to combine the genomic, proteomic and other omic profiles together in an attempt to obtain a broader vision of how a carcinoma progresses.

Conclusions
===========

The authors of this manuscript have presented a catalogue of salivary proteins which are altered in concentration as a consequence of the presence of ductal carcinoma of the breast. These findings are supported by other investigators employing proteomic analysis of breast cancer cell lines, breast cancer tissues, tissue microenvironment and serum[@b79][@b80][@b81]. Additionally, nearly 29% of the panel of proteins has been technically validated by either western blot or by ELISA. A breakdown of these proteins has also been analyzed according staging and Her2/neu receptor status[@b12][@b82]. The investigators have also found that the protein concentrations can be modulated while undergoing cancer treatment and respond differently according pathological cell type[@b9].

The main question arising from this line of research is how can tumors that are remote from the oral cavity influence salivary protein profiles? The prominent hypothesis to explain the aforementioned phenomenon is that exosomes which are shed and escape extracellular breakdown diffuse throughout the body and appear in biological fluids such as blood, urine, saliva semen breast milk, nipple aspirates and malignant effusions[@b83]. In doing so, they initiate exosome-mediated cell-to-cell communication by fusing with membranes of their cellular targets[@b84][@b85]. Upon entering the cellular he cytoplasm, their contents are released and activate downstream events in recipient cells[@b73]. It is also possible that extracellular proteases degrade the exosomes and their contents become soluble ligands binding to cell surface receptors. Experimentally, it has been demonstrated by Lau *et al*. that breast cancer-derived exosomes communicated and activated transcription within salivary gland cells and alter the proteomic composition of salivary gland cell-derived exosomes[@b86].

[Table 2](#t2){ref-type="table"} illustrates the presence of proteins carried by both salivary gland cell-derived exosomes and breast cancer-derived exosomes with 20 of the proteins being common to both cell types. The finding is circumstantial at this point in time as exosome research is in its infancy; however, as research continues in this field one could expect further support for the proposed mechanism for salivary protein alterations[@b73][@b74][@b83][@b84][@b85].

In summary, the manuscript proposes a novel method for studying breast cancer progression which includes the tumor microenvironment and inflammatory progress[@b87]. Clinically, many of the markers have shown utility for monitoring treatment efficacy and tumor recurrence. Several proteins such as Lung Resistance Protein may be useful as a prognostic indicator. Additionally, key pathway markers such as EGFR, E-Cadherin, p53, Apaf-1, 14-3-3δ, Xiap, p21^WAF−1^ and others could be placed in a microarray assay and render a probability (risk assessment) of having carcinoma of the breast rather than a "yes or no" response which is subject to many false positive and negative assessments.

Further research is required in order determine the effects of tumor and tumor receptor phenotypes and the alteration of the panel as the tumor progresses from one stage to the next. It is also important to know which proteins from the profile are associated with tumor dormancy and tumor resistance to therapy. Considering that the salivary protein profile was modified secondary to the presence of a tumor remote from the oral cavity, it may provide information on the metastatic process which is the main cause of death for breast cancer patients.

Methods and Materials
=====================

Proteomic Design
----------------

The investigators analyzed pooled, stimulated whole saliva specimens. Each pooled specimen within a cohort consisted of ten individual patient saliva specimens from a bank of control and cancer specimens frozen at −80 °C. One pooled saliva specimen consisted of ten specimens from ten healthy volunteers, another specimen was a pooled saliva specimen from ten subjects diagnosed with ductal carcinoma *in situ* (DCIS)[@b10]. Similarly assembled pooled specimens came from Stage I, Stage IIa, Stage IIb, Her2/*neu* positive and Her2/negative ductal carcinoma volunteers[@b11][@b12]. The cancer cohort, internally, was estrogen and progesterone receptor status negative as determined by the pathology report. All subjects were closely matched for age and race and were non-tobacco users.

The study was conducted in accordance with the Declaration of Helsinki, and the University of Texas Health Science Center Institutional Review Board approved the protocol and informed consent form prior to study initiation. All participating volunteers were explained their participation rights and signed an IRB consent form. The saliva specimens and related patient data are non-linked and bar coded in order to protect patient confidentiality. This study was performed under the UTHSC IRB approved protocol\# HSC-DB-05-0394.

To increase accuracy and assure reproducibility, a duplicate set of specimens were sent to the Harvard Partners Center for Genetics and Genomics, Cambridge, MA., and were proteomically analyzed using both bottom-up and gel based approaches. A Thermo Finnigan LTQ FT ICR Hybrid Mass Spectrometer was used for the proteome analysis.

In order to present a complete catalogue of salivary cancer related proteins, proteins from previous studies were added to this analysis. These proteins were determined by either antibody array and/or by ELISA[@b8][@b9][@b10]. The reason for adding these antibody based protein determinations was to provide information concerning the presence of some of the low abundance proteins that were changed secondary to carcinoma of the breast.

Saliva Collection and Sample Preparation
----------------------------------------

Stimulated whole salivary gland secretion is a reflex response occurring during the mastication of a bolus of food. Usually, a standardized bolus (1 gram) of paraffin or a gum base (generously provided by the Wrigley Co., Peoria, IL) is given to the subject to chew at a regular rate. The individual, upon sufficient accumulation of saliva in the oral cavity, expectorates periodically into a preweighed disposable plastic cup between the hours of 8:00 a.m. and 5:00 p.m. As this is a reflexive collection, circadian rhythms are not a factor on salivary flow rates[@b10]. This procedure is continued for a period of five minutes. The volume and flow rate is then recorded along with a brief description of the specimen's physical appearance[@b11]. Saliva specimens tainted with the presence of blood were not used in the study. The cup with the saliva specimen is reweighed and the flow rate determined gravimetrically. The specimens were placed on ice and immediately transported from the clinic to the laboratory for processing. Specimens were collected by one calibrated individual working in the same location.

The specimens were aliquoted and centrifuged in an Eppendorf centrifuge 5415R with temperature control (4 °C) for five minutes in order to remove debris and any unwanted particulates. The supernants were removed and a protease cocktail inhibitor (trypsin, calpain, papain, cathepsin B, chymotrypsin, kallikrein, human leukocyte elastase and aminopeptidases) from Sigma Co (St. Louis, MI, USA) was added along with enough dithiothreitol from a 1 M stock solution to bring its concentration 1 mM. The 1 ml aliquots were frozen at −80 °C[@b11].

Bottom-Up Mass Spectrometry Using iTRAQ Labeling
------------------------------------------------

Briefly, the saliva samples were thawed and immediately centrifuged to remove insoluble materials[@b10][@b11][@b12]. The supernatants were assayed for protein using the Bio-Rad protein assay (Hercules, CA, USA) and an aliquot containing 100 μg of each specimen was precipitated with 6 volumes of −20 °C acetone. Specimens were normalized for analysis by using total protein concentrations. The precipitate was resuspended and treated according to the manufacturer's instructions. Protein digestion and reaction with iTRAQ labels were carried out as previously described and according to the manufacturer's instructions (Applied Biosystems, Foster City, CA). Briefly, the acetone precipitable proteins were centrifuged in a table top centrifuge at 15,000 × g for 20 minutes. The acetone supernatants were removed and their pellets resuspended in 20 ul dissolution buffer. The soluble fractions were denatured and the disulfides reduced by incubation in the presence of 0.1% SDS and 5 mM TCEP (tris-(2-carboxyethyl)phosphine)) at 60 °C for one hour. Cysteine residues were blocked by incubation at room temperature for 10 minutes with MMTS (methyl methane-thiosulfonate). Trypsin was added to the mixture to a protein: trypsin ratio of 10:1. The mixtures were incubated overnight at 37 °C. The protein digests were labeled by mixing with the appropriate iTRAQ reagent and incubating at room temperature for one hour. On completion of the labeling reaction, the four separate iTRAQ reaction mixtures were combined. Since there are a number of components that can interfere with the LC-MS/MS analysis, the labeled peptides were partially purified by a combination of strong cation exchange followed by reverse phase chromatography on preparative columns. The combined peptide mixtures were diluted 10 fold with loading buffer (10 mM KH~2~PO~4~ in 25% acetonitrile at pH 3.0) and applied by syringe to an ICAT Cartridge-Cation Exchange column (Applied Biosystems, Foster City, CA) column that has been equilibrated with the same buffer.

The column is washed with 1 ml loading buffer to remove contaminants. To improve the resolution of peptides during LC-MS/MS analysis, the peptide mixtures were partially purified by elution from the cation exchange column in 3 fractions. Stepwise elution from the column was achieved with sequential 0.5 ml aliquots of 10 mM KH~2~PO~4~ at pH 3.0 in 25% acetonitrile containing 116 mM, 233 mM and 350 mM KCl respectively. The fractions were evaporated Speed Vac to about 30% of their volume to remove the acetonitrile and then slowly applied to an Opti-Lynx Trap C18 100 ul reverse phase column (Alltech, Deerfield, IL) with a syringe. The column was washed with 1 ml of 2% acetonitrile in 0.1% formic acid and eluted in one fraction with 0.3 ml of 30% acetonitrile in 0.1% formic acid. The fractions were dried by lyophilization and resuspended in 10 ul 0.1% formic acid in 20% acetonitrile. Each of the three fractions was analyzed by reverse phase LC-MS/MS.

Reverse Phase LC-MS/MS
----------------------

The desalted and concentrated peptide mixtures were quantified and identified by nano-LC-MS/MS on an API QSTAR XL mass spectrometer (ABS Sciex Instruments) operating in positive ion mode. The chromatographic system consists of an UltiMate nano-HPLC and FAMOS autosampler (Dionex LC Packings). Peptides were loaded on a 75 μm × 10 cm, 3 μm fused silica C18 capillary column, followed by mobile phase elution: buffer (A) 0.1% formic acid in 2% acetonitrile/98% Milli-Q water and buffer (B): 0.1% formic acid in 98% acetonitrile/2% Milli-Q water. The peptides were eluted from 2% buffer B to 30% buffer B over 180 minutes at a flow rate 220 nL/min. The LC eluent was directed to a NanoES source for ESI/MS/MS analysis. Using information-dependent acquisition, peptides were selected for collision induced dissociation (CID) by alternating between an MS (1 sec) survey scan and MS/MS (3 sec) scans. The mass spectrometer automatically chooses the top two ions for fragmentation with a 60 s dynamic exclusion time. The IDA collision energies parameters were optimized based upon the charge state and mass value of the precursor ions.

Random control and cancer specimens from the specimen bank were selected and blindly sent for proteomic analysis to ascertain quantification repeatability and to address issues of variability, proteomic inconsistency and issues (pooled variance) surrounding the use of pooled specimens. Additionally, western blots were performed on both pooled and individual specimens for technical validation[@b88][@b89][@b90][@b91].

Bioinformatics and Statistical Methods
--------------------------------------

The accumulated LC-MS/MS spectra were analyzed by ProQuant and ProGroup software packages (Applied Biosystems) using the SwissProt database for protein identification. The ProQuant analyses were carried out with a 75% confidence cutoff with a mass deviation of 0.15 Da for the precursor and 0.1 Da for the fragment ions. The ProGroup reports were generated with a 95% confidence level for protein identification.

The Swiss-Prot database was employed for protein identification while the PathwayStudio^®^ bioinformatics software package was used to determine Venn diagrams were also constructed using the NIH software program (<http://ncrr.pnl.gov>). Pathways were retrieved from three databases: DAVID, KEGG, BioCarta, and the NCI's Protein Interaction Database (PID)[@b86][@b92][@b93][@b94][@b95]. Gene ontologies were determined by employing the GO and AmiGO databases[@b95][@b96].

Routine statistical evaluations were performed using the IBM SPSS Statistics 23 software. These evaluations include frequency, cross-tabulations and descriptive statistics. Mean comparisons were performed using parametric statistical analysis.
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###### A Catalogue of Salivary Proteins Altered Secondary to Breast Cancer.

  UniProt                                                                   Gene      Protein Name                          Function                                                    Stage
  --------------------------------------------------------------------- ------------- ------------------------------------- --------------------------------------------------- ----------------------
  **Genomic Integrity Related Proteins (10, 4% of total)**                                                                                                                      
  P16403                                                                     H12      Histone H1.2                          Transcription, DNA repair, replication                    IIa, H^+^
  **Q8IUE6**                                                              **H2A2B**   **Histone H2A**                       **Transcription, DNA repair, replication**                   IIb
  P16104                                                                    H2AX      Histone H2A.x (H2a/x)                 Transcription, DNA repair, replication                    IIa, H^+^
  **Q99880**                                                              **H2B1L**   **Histone H2B type 1-L**              **Transcription, DNA repair, replication**                IIb, H^+^
  Q99877                                                                    H2B1N     Histone H2B type 1-N                  Transcription, DNA repair, replication                        0
  Q16778                                                                    H2B2E     Histone H2B type 2-E                  Transcription, DNA repair, replication                    IIa, H^+^
  **Q71DI3**                                                               **H32**    **Histone H3.2**                      **Transcription, DNA repair, replication**                IIa, H^+^
  **P62805**                                                               **H4**     **Histone H4**                        **Transcription, DNA repair, replication**                IIa, H^+^
  P12004                                                                    PCNA      Prolif. cell nuclear antigen          DNA repair                                                IIa, H^+^
  **P35637**                                                               **TLS**    **TLS Oncogene**                      **Maintenance of genomic integrity**                      IIa, H^+^
  **Molecular Chaperones/Heat Shock Proteins (14, 6% of total)**                                                                                                                
  **Q99933**                                                              **BAG-1**   **BAG chaperone reg. 1**              **Inhibits chaperone activity HSP70/HSC70**          0, I, IIa, IIb, H^+^
  Q6P5S2                                                                    CF058     C6orf58                               Chromosome 6 open reading frame 58                        IIa, H^+^
  **P14211**                                                              **CRP55**   **Calreticulin**                      **Major endoplasmic reticular activity**             0, I, IIa, IIb, H^+^
  P11021                                                                    GRP78     Glucose-regulated protein             Assembly multimeric prot. complexes                       IIa, H^+^
  P11142                                                                    HSP10     Heat Shock 10 protein                 Repressor of transcriptional activation                      IIb
  Q12988                                                                    HSP27     Heat Shock 27 protein                 Inhibitor of actin polymerization                           I, IIa
  P25685                                                                    Hsp40     Heat shock protein 40                 Interacts with HSP70                                      IIa, H^+^
  P08107                                                                    HSP70     Heat Shock 70 protein                 Stabilizes preexistent proteins - aggregation        0, I, IIa, IIb, H^+^
  **P20585**                                                              **MSH3**    **DNA repair protein**                **Post-replicative DNA mismatch repair sys**              IIa, H^+^
  P05307                                                                     PDI      Protein disulfide isomerase;          Catalyzes the rearrangement of -S-S- bonds                IIa, H^+^
  **P07237**                                                              **PDIA1**   **Protein disulfide-isomerase**       **Catalyzes rearrangement of -S-S- bonds**                   IIb
  **P62937**                                                              **PPIA**    **Peptidyl-prolyl isomerase A**       **PPIases accelerate the folding of proteins**          IIa, IIb, H^+^
  **P23284**                                                              **PPIB**    **Peptidyl-prolyl isomerase B**       **PPIases accelerate the folding of proteins**          IIa, IIb, H^+^
  **Q13546**                                                               **RIP**    **Recept.-interacting protein 1**     **DNA damage repair**                                     IIa, H^+^
  **Cell Growth Related Proteins (17, 7% of total)**                                                                                                                            
  **P63104**                                                              **1433Z**   **14-3-3 protein zeta/delta**         **Protein kinase C inhibitor**                               IIb
  P31749                                                                    AKT-1     α- serine/threonine-prot. kinase      Cell survival, growth & angiogenesis                      IIa, H^+^
  P04040                                                                    CATA      Catalase                              Promotes growth of cells                                   IIa, IIb
  **P32577**                                                               **Csk**    **Tyrosine-protein kinase CSK**       **Regulates cell growth**                                 IIa, H^+^
  P01133                                                                     EGF      epidermal growth factor               Stimulates growth of epid. & epith. tissues          0, I, IIa, IIb, H^+^
  P00533                                                                    EGFR      epidermal growth factor recep.        EGF receptor                                         0, I, IIa, IIb, H^+^
  P09038                                                                     FGF      Fibroblastic growth factor            Growth factor                                             IIa, H^+^
  P15692                                                                    VEGF      Vasc. Endothel. Growth Factor         Plays an important role in angiogenesis                   IIa, H^+^
  P29354                                                                    GRB2      Growth factor recept. protein 2       Links cell surface growth factor receptor                 IIa, H^+^
  P04626                                                                  HER2/neu    Epid. growth factor receptor 2        EGF receptor                                          0, I, IIa, IIb, H+
  P15531                                                                    NDKA      Nucleoside diphosphate kin. A         Cell proliferation, differentiation                       IIa, H^+^
  **P29474**                                                              **NOS3**    **Nitric oxide synthase**             **Mediates vascular angiogenesis**                        IIa, H^+^
  P29476                                                                    NOSI      NOS type I                            Nitric oxide producer                                     IIa, H^+^
  **P20936**                                                             **Ras-GAP**  **Ras GTPase-act. prot. 1**           **Inhibitory reg. Ras-cyclic AMP pathway**                IIa, H^+^
  P25815                                                                    S100P     S100-P                                Stimulate cell proliferation                                  0
  Q9UKW4                                                                    VAV3      VAV 3 oncogene                        Plays an important role in angiogenesis                   IIa, H^+^
  P01135                                                                    TGF-α     Transforming growth factor α          Potent mitogenic polypeptide                         0, I, IIa, IIb, H^+^
  **Apoptosis Related Proteins (13, 5% of total)**                                                                                                                              
  **P31947**                                                              **1433S**   **14-3-3 protein sigma**              **p53 regulated inhibitor**                                IIa, IIb
  **O14727**                                                             **Apaf-1**   **Apop. prot. activity factor-1**     **Apoptosis activity**                                    IIa, H^+^
  P99999                                                                     CYC      Cytochrome c                          Apoptosis activity                                        IIa, H^+^
  **P10909**                                                               **CLU**    **Clusterin**                         **Apoptosis activity**                                 0, I, IIa, H^+^
  P80188                                                                    NGAL      Oncogene 24p3                         Involved apoptosis, innate immunity                        IIa, IIb
  P38936                                                                     p21      WAF-1                                 Inhibitor of cellular proliferation                     IIa, IIb, H^+^
  P04637                                                                     p53      protein 53                            Apoptosis                                                IIa, IIb, H+
  **P19525**                                                               **PKR**    **p68 kinase**                        **Apoptosis, cell proliferation**                         IIa, H^+^
  P62988                                                                    UBIQ      Ubiquitin                             Apoptosis                                               IIa, IIb, H^+^
  P98170                                                                    XIAP      E3 ubiquitin-protein ligase XIAP      Apoptosis                                                 IIa, H^+^
  P04156                                                                    PRIP      Protein prion                         Possible apoptotic activity                                  IIa
  O43550                                                                   CDC25B     CDC25B                                Tyrosine phosphatase activity                             IIa, H^+^
  P01375                                                                    TNF-α     Tumor necrosis factor alpha           Induces cell death.                                     0, I, IIa, IIb
  **Immunity Related Proteins (52, 22% of total)**                                                                                                                              
  **P02763**                                                              **A1AG1**   **Alpha-1 acid glycoprotein 1**       **Anti-inflammatory activity**                          IIa, IIb, H^+^
  P61769                                                                    B2MG      Beta-2 microglobulin precursor        Component of the MHC I complex                               IIa,
  **Q8N4F0**                                                              **BPIL1**   **Palate, lung & nasal epith.**       **Involved in the innate immune response**             0, I, IIa, H^+^
  **P01024**                                                               **C3**     **Complement C3 precursor**           **Effector of innate and adaptive immunity**         0, I, IIa, IIb, H^+^
  P0C0L4                                                                     C4       Complement 4A                         Of the classical complement pathway                  0, I, IIa, IIb, H^+^
  **P28907**                                                              **CD38**    **ADP-ribosyl cyclase 1**             **Receptor in cells of the immune system**                IIa, H^+^
  P53618                                                                    COPB      Coatomer subunit beta                 Degradation of CD4 & MHC I antigens                          IIa
  **P54108**                                                              **CRIS3**   **Cysteine-rich secret. prot. 3**     **Ligand of alpha1B-glycoprotein in plasma**               0, IIa,
  **Q9UGM3**                                                              **DMBT1**   **GP 300**                            **Interaction of tumor cells & immune system**            IIa, H^+^
  **P08246**                                                              **ELNE**    **Leukocyte elastase**                **Modifier of monocytes & granulocytes**                  IIa, H^+^
  P06241                                                                     FYN      Fyn-Tyrosine-protein kinase           Regulates cell growth                                     IIa, H^+^
  P01762                                                                    HV301     Ig heavy chain V-III region TRO       Fc-epsilon receptor signaling pathway                        IIb
  **P01777**                                                              **HV316**   **Ig heavy chain V-III region TEI**   **Fc-epsilon receptor signaling pathway**                 IIa, H^+^
  P01781                                                                    HV320     Ig heavy chain VIII region GAL        Complement activation                                      IIa, IIb
  P01579                                                                    IFN-γ     Interferon gamma                      Potent activator of macrophages                      0, I, IIa, IIb, H^+^
  P01876                                                                    IGHA1     Ig alpha1 chain C region              Defends against local infection                            IIa, IIb
  P01877                                                                    IGHA2     Ig alpha-2 chain C region             Defends against local infection                           IIb, H^+^
  **P01857**                                                              **IGHG1**   **Ig gamma-1 chain C region**         **Complement activation**                            0, I, IIa, IIb, H^+^
  P01859                                                                    IGHG2     Ig gamma-2 chain C region             Complement activation                                     IIb, H^+^
  P01591                                                                     IGJ      Immunoglobulin J chain                Links two monomer units of IgM or IgA                      IIa, IIb
  P05112                                                                    IL 4      Interleukin - 4                       Activates B-cell and T-cell proliferation               0, I, IIa, IIb
  P05231                                                                    IL 6      Interleukin - 6                       Inducer of the acute phase response                     0, I, IIa, IIb
  P10145                                                                    IL 8      Interleukin - 8                       A chemotatic factor                                     0, I, IIa, IIb
  P22301                                                                    IL-10     Interleukin - 10                      Cytokine Inhibitor (IFN-γ, IL-2, IL-3, TNF)             0, I, IIa, IIb
  P18510                                                                    IL1RA     Interleukin-1 recept. antagonist      Antagonist to IL-1 alpha, beta                            IIa, H^+^
  Q9BY25                                                                    IL1β      IL-1beta                              Inhibits neutrophil apoptosis                           0, I, IIa, IIb
  **P30740**                                                              **ILEU**    **Leukocyte elastase inhibitor**      **Regulates neutrophil proteases**                           IIb
  P01834                                                                     KAC      Ig kappa chain C region               immunoglobulin κ chains                                 IIa, IIb, H^+^
  P06870                                                                    KLK1      Kallikrein-1 precursor                Cleaves Met-Lys and Arg-Ser bonds                       0, I, IIa, IIb
  P06309                                                                    KV205     Ig kappa chain V-II region            Fc-epsilon receptor signaling pathway                     IIa, H^+^
  P18135                                                                    KV312     Ig kappa chain VIII region HAH        Surface immunoglobulin M autoantibody                      IIa, IIb
  P01842                                                                     LAC      Ig lambda chain C regions             Complement activation                                     IIa, H^+^
  P06239                                                                     LCK      Lck-Tyrosine-protein kinase           Selection & maturation of T-cells in thymus               IIa, H^+^
  P31025                                                                    LCN1      Lipocalin1 precursor                  Regulates activity of neutrophil proteases           0, I, IIa, IIb, H^+^
  P13500                                                                    MCP-1     Monocyte chemotactic prot.-1          Chemotactic factor attracts monocytes                   0, I, IIa, IIb
  O88888                                                                    Mint3     Minit-3                               Activates macrophages                                     IIa, H^+^
  P22894                                                                    MMP8      Matrix metalloproteinase-8            Degrades fibrillar type I, II & III collagens             IIa, H^+^
  **P14780**                                                              **MMP9**    **Matrix metalloproteinase-9**        **Basement membrane dissolution**                         IIa, H^+^
  **P01871**                                                               **MUC**    **Ig mu chain C region**              **Role in primary defense mechanisms**                I, IIa, IIb, H^+^
  **O43240**                                                              **NES1**    **Kallikrein 10**                     **Tumor suppressor in breast cancer**                     IIa, H^+^
  **P22079**                                                              **PERL**    **Lactoperoxidase**                   **Airway host defense against infection**             0, IIa, IIb, H^+^
  **P05164**                                                              **PERM**    **Myeloperoxidase**                   **Host defense system of leukocytes**                   IIa, IIb, H^+^
  **P01833**                                                              **PIGR**    **Poly-IG receptor protein**          **Binds IgA & IgM at basolateral surface**              IIa, IIb, H^+^
  **P12273**                                                               **PIP**    **Prolactin-inducible protein**       **Pathological conditions mammary gland**                I, IIa, IIb
  P13796                                                                    PLSL      Plastin-2                             Modulates cell surface expression IL2RA/CD25              IIa, H^+^
  Q9NP55                                                                    PLUNC     BPI fold-containing family A1         Associated with tumor progression                       0, I, IIa, IIb
  P13501                                                                   RANTES     RANTES                                Chemokine (CCL5)                                        0, I, IIa, IIb
  P13405                                                                     Rb       Retinoblastoma-assoc. prot.           Acts as a tumor suppressor                                IIa, H^+^
  P29508                                                                    SPB3      Serpin B3                             Immune response against tumor cells                       IIa, H^+^
  **P42224**                                                              **Stat1**   **Transcription factor ISGF-3**       **Mediates responses to cytokines**                       IIa, H^+^
  P01135                                                                    TGF-α     Transforming growth factor α          Potent mitogenic polypeptide                            0, I, IIa, IIb
  P01375                                                                    TNF-α     Tumor necrosis factor alpha           Secreted to induce cell death                           0, I, IIa, IIb
  **Cytoskeleton Related Proteins (40, 17% of total)**                                                                                                                          
  P63261                                                                    ACTG      Actin, cytoplasmic 2                  Cytoskeleton                                              IIa, H^+^
  **Q01518**                                                              **CAP1**    **Adenylyl cyclase**                  **Actin cytoskeleton organization**                       IIa, H^+^
  **P12830**                                                              **CDH1**    **Cadherin-1**                        **Epithelial Adherens junction protein**                  IIa, H^+^
  P06731                                                                     CEA      Carcin-embryonic antigen              Cell adhesion and in intracellular signaling         0, I, IIa, IIb, H^+^
  P23528                                                                    COF1      Cofilin, non-muscle isoform           Cytoskeleton                                              IIa, H^+^
  **Q02487**                                                              **DSC2**    **Desmocollin-2 precursor**           **Intercellular desmosome junctions**                        IIb
  P15311                                                                    EZRI      Ezrin                                 Cytoskeleton                                            0, I, IIa, IIb
  **P02671**                                                              **FIBA**    **Fibrinogen α chain precursor**      **Involved in cell adhesion, cell motility**                 IIa,
  P02675                                                                    FIBB      Fibrinogen beta chain precursor       Involved in cell adhesion, cell motility                0, I, IIa, IIb
  P06396                                                                    GELS      Gelsolin                              Assembly of monomers into filaments                       IIa, H^+^
  **Q15151**                                                               **JUP**    **g-Catenin**                         **Associated with desmosome junctions**                   IIa, H^+^
  **P13646**                                                              **K1C13**   **Cytokeratin-13**                    **Cytoskeleton protein**                              0, IIa, IIb, H^+^
  **P08779**                                                              **K1C16**   **Cytokeratin-16**                    **Cytoskeleton protein**                                0, I, IIa, IIb
  P35527                                                                    K1C9      Cytokeratin-9                         Cytoskeleton protein                                 0, I, IIa, IIb, H^+^
  **P04264**                                                              **K2C1**    **Cytokeratin 1**                     **Cytoskeleton protein**                             0, I, IIa, IIb, H^+^
  **P19013**                                                              **K2C4**    **Cytokeratin 4**                     **Cytoskeleton protein**                                  IIa, H^+^
  **P13647**                                                              **K2C5**    **Cytokeratin-5**                     **Cytoskeleton protein**                             0, I, IIa, IIb, H^+^
  **P02538**                                                              **K2C6A**   **Cytokeratin-6A**                    **Cytoskeleton protein**                             0, I, IIa, IIb, H^+^
  P48666                                                                    K2C6C     Cytokeratin 6C                        Cytoskeleton protein                                          0,
  P13645                                                                    KRT10     Cytokeratin-10                        Cytoskeleton protein                                 0, I, IIa, IIb, H^+^
  P02533                                                                    KRT14     Cytokeratin-14                        Cytoskeleton protein                                      0, I, IIb,
  P19012                                                                    KRT15     Cytokeratin-15                        Cytoskeleton protein                                       I, IIa,
  Q04695                                                                    KRT17     Cytokeratin-17                        Cytoskeleton protein                                 0, I, IIa, IIb, H^+^
  P08727                                                                    KRT19     Cytokeratin-19                        Cytoskeleton protein                                         IIa
  P35908                                                                    KRT2      Cytokeratin 2                         Cytoskeleton protein                                 0, I, IIa, IIb, H^+^
  Q7Z3Z0                                                                    KRT25     Cytokeratin-25                        Cytoskeleton protein                                      IIa, H^+^
  P08729                                                                    KRT7      Cytokeratin-7                         Cytoskeleton protein                                    0, I, IIa, IIb
  P22894                                                                    MMP8      Matrix metalloproteinase-8            Degrades fibrillar type I, II & III collagens             IIa, H^+^
  P14780                                                                    MMP9      Matrix metalloproteinase-9            Basement membrane dissolution                             IIa, H^+^
  P26038                                                                    MOES      Moesin                                Involved in major cytoskeletal structures                 IIa, H^+^
  P49024                                                                  Paxillin    Paxillin                              Involved in actin-membrane attachment                     IIa, H^+^
  **P07737**                                                              **PROF1**   **Profilin-1**                        **Binds to actin & affects the cytoskeleton**         0, IIa, IIb, H^+^
  P03749                                                                     Rho      Rho                                   Regulates intracellular actin dynamics                    IIa, H^+^
  **P31949**                                                              **S10AB**   **S100-A11**                          **Cornification of keratinocytes**                           IIa,
  P35321                                                                    SPR1A     Cornifin-A                            Keratinization activity                               I, IIa, IIb, H^+^
  P22528                                                                    SPR1B     Cornifin-B                            Keratinization activity                                   IIb, H^+^
  Q9UBC9                                                                    SPRR3     Cornifin beta                         Envelope protein of keratinocytes                        0, IIa, H^+^
  P10636                                                                     TAU      Microtubule-associated prot. - τ      Promotes microtubule assembly and stability               IIa, H^+^
  P62328                                                                    TYB4      Thymosin beta 4                       Role in the organization of the cytoskeleton                 IIa,
  **P08670**                                                              **VIME**    **Vimentin**                          **Class-III intermediate filaments**                    IIa, IIb, H^+^
  **Metabolism Related Proteins (56, 24% of total)**                                                                                                                            
  P22303                                                                    ACTH      Acetylcholinesterase                  Signal transduction at NMJ                                IIa, H^+^
  P07108                                                                    ACBP      AcylCoA binding protein               Binds medium & long-chain acyl-CoA                        IIa, H^+^
  Q15848                                                                    ADIPO     Adiponectin                           Adipokine involved in fat metabolism                 0, I, IIa, IIb, H^+^
  Q9DCT1                                                                    AK1E1     Aldo-keto reductase                   Catalyst                                                      0,
  **P04217**                                                              **A1BG**    **Alpha-1B-glycoprotein**             **Functions as transport protein in blood**               IIa, H^+^
  P01023                                                                    A2MG      Alpha-2 macroglobulin                 Proteinase inhibitor                                    IIa, IIb, H^+^
  Q92746                                                                   ST8SIA2    Alpha-2,8-sialyltransferase 8B        Protein modification; protein glycosylation               IIa, H^+^
  **P19961**                                                              **AMYC**    **Alpha-amylase 2B precursor**        **Carbohydrate metabolism**                             0, I, IIa, IIb
  **P06733**                                                              **ENOA**    **Alpha-enolase**                     **Enzyme that has a role in glycolysis**                IIa, IIb, H^+^
  P03973                                                                    ALK1      Antileukoproteinase 1 precursor       Proteinase inhibitor                                      IIa, H^+^
  **P02647**                                                              **APOA1**   **Apolipoprotein A-I**                **Promotes efflux of cholesterol from cell**              IIb, H^+^
  **P02649**                                                              **APO-E**   **Apolipoprotein -E**                 **Catabolizes lipoproteins**                              IIa, H^+^
  P06576                                                                    ATPB      ATP synthase subunit beta             ATP synthesis                                            0, IIa, IIb
  Q8WZ76                                                                    BCRP      Breast cancer resistance prot.        ATP hydrolysis-dependent efflux transport                     I
  P00915                                                                    CAH1      Carbonic anhydrase 1                  Reversible hydration of carbon dioxide                       IIb,
  **P23280**                                                              **CAH6**    **Carbonic anhydrase 6**              **Reversible hydration of carbon dioxide**              0, I, IIa, IIb
  P07339                                                                    CATD      Cathepsin D                           Pathogenesis of breast cancer                        0, I, IIa, IIb, H^+^
  P01040                                                                    CYTA      Cystatin A                            Protease inhibitor                                     0, I, IIa, H^+^
  **P04080**                                                              **CYTB**    **Cystatin B**                        **Intracellular thiol proteinase inhibitor**            IIa, IIb, H^+^
  **P01034**                                                              **CYTC**    **Cystatin C**                        **Local regulator of this enzyme activity**          0, I, IIa, IIb, H^+^
  **P28325**                                                              **CYTD**    **Cystatin-D**                        **Proteinase inhibitor**                             0, I, IIa, IIb, H^+^
  **P01036**                                                              **CYTS**    **Cystatin-S precursor**              **Protein inhibits papain and ficin**                   0, I, IIa, IIb
  **P09228**                                                              **CYTT**    **Cystatin-SA precursor**             **Thiol protease inhibitor**                            IIa, IIb, H^+^
  **P01037**                                                              **CYTN**    **Cystatin-SN precursor**             **Cysteine proteinase inhibitors**                         IIa, IIb
  P20813                                                                   CYP2B6     Cytochrome p450                       NADPH-dependent electron transport                   0, I, IIa, IIb, H^+^
  Q01469                                                                    FABPE     Fatty acid binding protein            Involved in keratinocyte differentiation                  IIa, H^+^
  **P80303**                                                              **NUCB2**   **Gastric cancer antigen Zg4**        **Calcium-binding protein**                           0, IIa, IIb, H^+^
  **P06744**                                                              **G6PI**    **Glucose-6-phosphate isom.**         **Glycolytic enzyme**                                        IIb
  **P09211**                                                              **GSTP1**   **Glutathione S-transferase P**       **Regulates negatively CDK5 activity**                  IIa, IIb, H^+^
  **P00738**                                                               **HPT**    **Haptoglobin precursor**             **Captures & combines with hemoglobin**               0, IIa, IIb, H^+^
  Q9Y5Z4                                                                    HEBP2     Heme-binding protein 2                Promotes mitochondrial permeability transition               IIa
  P69905                                                                     HBA      Hemoglobin subunit alpha              Oxygen transport from lung                                IIb, H^+^
  P68871                                                                     HBB      Hemoglobin subunit beta               Oxygen transport from lung                                IIb, H^+^
  P02790                                                                    HEMO      Hemopexin precursor                   Binds heme and transports to liver                           IIb
  **P04075**                                                              **ALDOA**   **Fructose biphosphate aldol.**       **Role in glycolysis & gluconeogenesis**                   IIa, IIb
  Q14764                                                                     LRP      Lung resistance-related protein       Role in nucleo-cytoplasmic transport                          I
  P40926                                                                    MDHM      Malate dehydrogenase                  Catalytic activity                                    0, IIa, IIb, H^+^
  O15438                                                                    MRDP      Multidrug resistance protein          Inducible transporter of organic anions                       I
  **Q06830**                                                              **PRDX1**   **Peroxiredoxin-1**                   **Redox regulation of the cell**                        IIa, IIb, H^+^
  P30041                                                                    PRDX6     Peroxiredoxin-6                       Redox regulation of the cell                                 IIa,
  P00558                                                                    PGK1      Phosphoglycerate kinase 1             Glycolytic enzyme                                       IIa, IIb, H^+^
  Q96PX9                                                                    PKH4B     Pleckstrin family G member 4B         PH domains bind various proteins                             IIa,
  P20742                                                                     PZP      Pregnancy zone protein                Inhibits all four classes of proteinases             0, I, IIa, IIb, H^+^
  **P08129**                                                               **PP1**    **Protein phosphatase 1**             **Regulation of glycogen metabolism**                     IIa, H^+^
  **Q08188**                                                              **TGM3**    **Transglutaminase E**                **Formation of isopeptide cross-links**                   IIa, H^+^
  P14618                                                                    PKM2      Pyruvate kinase PKM2                  Caspase independent cell death of tumor cells           IIa, IIb, H^+^
  **P02768**                                                              **ALBU**    **Serum albumin precursor**           **Regulation of colloidal osmotic pressure**            0, I, IIa, IIb
  **P10599**                                                              **THIO**    **Thioredoxin**                       **Cytoplasmic antioxidant**                                  IIb
  **P37837**                                                              **TALDO**   **Transaldolase**                     **Balances metabolites**                                  IIb, H^+^
  P20061                                                                    TCO1      Transcobalamin1 precursor             Vitamin B12-binding protein                                IIa, IIb
  **P02787**                                                              **TRFE**    **Transferrin**                       **Iron transporter**                                  0, IIa, IIb, H^+^
  **P29401**                                                               **TKT**    **Transketolase**                     **Transfers ketol group to aldose acceptor**                 IIa,
  P60174                                                                    TPIS      Triosephosphate isomerase             Catalytic activity                                        IIa, H^+^
  P02774                                                                    VTDB      Vitamin D-binding protein             Transport                                                    IIb
  P25311                                                                    ZA2G      Zinc-alpha-2-glycoprotein             Stimulates lipid degradation in adipocytes                    0,
  Q96DA0                                                                    U773      Zymogen granule protein               Protein trafficking                                       IIa, H^+^
  **Membrane and Calcium Binding Related Proteins (17, 7% of total)**                                                                                                           
  **P04083**                                                              **ANXA1**   **Annexin A1**                        **Membrane fusion & exocytosis**                     0, I, IIa, IIb, H^+^
  **P46193**                                                              **ANXA1**   **Annexin I**                         **Membrane fusion & exocytosis**                     0, I, IIa, IIb, H^+^
  **P07355**                                                              **ANXA2**   **Annexin II**                        **Calcium-regulated membrane-binding prot.**         0, I, IIa, IIb, H^+^
  P12429                                                                    ANXA3     Annexin A3                            Inhibitor of phospholipase A2                                IIb,
  P02765                                                                    FETUA     Alpha-2-Z-globulin                    Promotes endocytosis                                       IIa, IIb
  P52566                                                                    GDIS      Rho GDP-dissociation inhib. 2         Regulates GDP/GTP exchange reaction                        IIa, IIb
  P20810                                                                    ICAL      Calpastatin                           Specific inhibition of calpain                               IIa,
  P97799                                                                     p24      Neurensin-1                           Role in neural organelle transport                        IIa, H^+^
  P15154                                                                    Rac1      p21 Rac-1                             Plasma membrane-associated small GTPase                   IIa, H^+^
  **P11233**                                                              **Ral A**   **Ras-related protein Ral-A**         **GTPase involved in cellular processes**                 IIa, H^+^
  P62158                                                                    CALM      Calmodulin                            Control of a large number of enzymes                         IIb
  P26447                                                                    S10A4     S100-A4                               Regulation of I-kappaB kinase/NF-kappaB                      IIa,
  **P06703**                                                              **S10A6**   **S100-A6**                           **Modulator of cellular calcium signaling**                  IIa,
  P31151                                                                    S100P     S100-A7                               Calcium binding protein                              0, I, IIa, IIb, H^+^
  **P05109**                                                              **S10A8**   **S100-A8**                           **Inflammatory processes, immune response**          0, I, IIa, IIb, H^+^
  **P06702**                                                              **S10A9**   **S100-A9**                           **Inflammatory processes, immune response**               0, I, IIa
  P80511                                                                    S10AC     S100-A12                              Binding protein, immune response                     0, I, IIa, IIb, H^+^
  **Oral Anti-Microbial Related Proteins (14, 6% of total)**                                                                                                                    
  P08311                                                                    CATG      Cathepsin G                           Antibacterial to Gram-negative bact.                        0, IIb
  P59666                                                                    DEF3      Neutrophil defensin 3                 Antimicrobial to Gram-negative/positive bact.            I, IIa, IIb
  **P15515**                                                              **HIS1**    **Histatin-1 precursor**              **Exhibit antibacterial & antifungal activities**          IIa, IIb
  **P61626**                                                              **LYSC**    **Lysozyme C precursor**              **Bacteriolytic function**                                 IIa, IIb
  **Q9HC84**                                                              **MUC5B**   **Mucin-5B precursor**                **Clearance of bacteria in the oral cavity**         0, I, IIa, IIb, H^+^
  Q8TAX7                                                                    MUC7      Mucin-7                               Clearance of bacteria in the oral cavity               0, I, IIa, H^+^
  **P02812**                                                              **PRB2**    **Salivary prol-rich prot. 2**        **Oral antimicrobial activity**                           IIa, H^+^
  Q16378                                                                    PROL4     Proline-rich protein 4                Antimicrobial activity                                    IIa, H^+^
  P02814                                                                    SMR3B     Submax. gland androgen-reg. 3         Salivary PRP                                           0, I, IIa, H^+^
  **Q96DR5**                                                              **SPLC2**   **Parotid secretory protein**         **Innate immune response**                           0, I, IIa, IIb, H^+^
  **P02788**                                                              **TRFL**    **Lactotransferrin**                  **Antimicrobial activity**                            0, IIa, IIb, H^+^
  **P02810**                                                              **PRPC**    **Acidic proline-rich prot.**         **Inhibitors of crystal growth**                           IIa, IIb
  P15941                                                                    MUC-1     Cancer antigen 15-3                   Adhesion and an anti-adhesion protein                0, I, IIa, IIb, H^+^
  Q02817                                                                    MUC-2     Mucin 2                               Mucosal protection                                         IIa, IIb

Note: The UniProt identification number, gene identification protein name and protein function are from UniProt database ([www.uniprot.org](http://www.uniprot.org)). The proteins are classified according to molecular function. Additionally all down-regulated proteins are bold; otherwise, the remaining proteins are up-regulated.

Staging Abbreviations: 0 = Stage 0, I = Stage I, IIa = Stage IIa, IIb = Stage IIb, H^+^ = Her2/neu positive.

###### Salivary Protein Presence in Breast Cancer Cell Lines and Exosomes.

  UniProt                                        Protein Name                          Method of Identification   Presence in Cell Lines   Exosomes In Saliva   Exosomes in T.T.                                                        Ref.
  ---------------------------------------------- ------------------------------------ -------------------------- ------------------------ -------------------- ------------------ ----------------------------------------------------------------------------------------------------------------
  **Genomic Integrity Related Proteins**                                                                                                                                          
  P16403                                         Histone H1.2                                     MS                        TT                                                                                                         [@b25]
  Q8IUE6                                         Histone H2A                                      MS                        TT                                                                                                         [@b25]
  Q99880                                         Histone H2B type 1-L (H2B.c)                     MS                        TT                                                                                                         [@b25]
  Q71DI3                                         Histone H3.2                                     MS                        TT                                                                                                         [@b28]
  P62805                                         Histone H4                                       MS                                              Yes                                                                                  [@b73]
  P12004                                         Prolif. cell nuclear antigen                     AA                      T, TT                                                                                                [@b8], [@b20], [@b77]
  **Molecular Chaperones/Heat Shock Proteins**                                                                                                                                    
  Q6P5S2                                         C6orf58                                        2D, MS                                            Yes                                                                                  [@b85]
  P27797                                         Calreticulin                                   MS, AA               S, B, M, MD, TT                                  Yes                                                  [@b8], [@b15], [@b16], [@b17],
  P11021                                         Glucose-regulated protein                        AA                 S, B, M, MD, TT              Yes                 Yes                                          [@b8], [@b15], [@b16], [@b17], [@b74], [@b85]
  P11142                                         Heat Shock 10 protein                            MS                                              Yes                 Yes                                                          [@b74], [@b85]
  Q12988                                         Heat Shock 27 protein                            MS                   B, M, MD, TT                                                                                            [@b14], [@b15], [@b16]
  P08107                                         Heat Shock 70 protein                            MS                     B, M, T                  Yes                 Yes                                                  [@b15], [@b16], [@b74], [@b85]
  P05307                                         Protein disulfide isomerase; p55                 AA                                              Yes                                                                  [@b8], [@b15], [@b16], [@b17], [@b85]
  P07237                                         Protein disulfide-isomerase                      MS                   B, M, MD, TT                                                                                            [@b14], [@b15], [@b16]
  P62937                                         Peptidyl-prolyl cis-trans isom. A                MS                   S, B, M, MD                Yes                 Yes                                              [@b15], [@b16], [@b17], [@b74], [@b85]
  **Cell Growth Related Proteins**                                                                                                                                                
  P63104                                         14-3-3 protein zeta/delta                        AA                   B, M, MD, TT               Yes                                                                      [@b8], [@b15], [@b18], [@b85]
  P00533                                         epidermal growth factor receptor                 E                        S, M                   Yes                 Yes                                                  [@b10], [@b17], [@b74], [@b85]
  P29354                                         Growth factor receptor protein 2                 AA                     S, M, MD                 Yes                                                                          [@b8], [@b17], [@b85]
  P04626                                         epidermal growth factor receptor2              WB, E                       S                     Yes                 Yes                                                  [@b10], [@b17], [@b74], [@b85]
  P15531                                         Metastatic process-associ. prot.                 AA                        M                                                                                                          [@b8]
  **Apoptosis Related Proteins**                                                                                                                                                  
  P31947                                         14-3-3 protein sigma                             MS                        TT                                                                                                     [@b18], [@b37]
  P38936                                         WAF-1                                          AA, E                       S                                                                                                  [@b8], [@b17], [@b39]
  P04637                                         protein 53                                       E                         TT                                                                                                     [@b8], [@b36]
  P62988                                         Ubiquitin                                      MS, WB                     S, B                   Yes                 Yes                                                  [@b15], [@b16], [@b17], [@b85]
  **Immunity Related Proteins**                                                                                                                                                   
  P61769                                         Beta-2 microglobulin precursor                   MS                       S, B                   Yes                 Yes                                              [@b15], [@b16], [@b17], [@b74], [@b85]
  Q8N4F0                                         Long palate, lung and nasal epith.               MS                                              Yes                 Yes                                                          [@b74], [@b85]
  Q9UGM3                                         GP 300                                           MS                                              Yes                                                                                  [@b85]
  P01579                                         Interferon gamma                                 AA                        TT                                                                                                     [@b8], [@b57]
  P01876                                         Ig alpha1 chain C region                         MS                                              Yes                                                                                  [@b85]
  P01877                                         Ig alpha-2 chain C region                        MS                                              Yes                                                                                  [@b85]
  P01857                                         Ig gamma-1 chain C region                        MS                                              Yes                                                                              [@b15], [@b85]
  P01859                                         Ig gamma-2 chain C region                        MS                                              Yes                                                                                  [@b85]
  P01591                                         Immunoglobulin J chain                           MS                                              Yes                                                                                  [@b85]
  P05112                                         Interleukin - 4                                AA, E                       TT                                                                                                 [@b8], [@b10], [@b87]
  P05231                                         Interleukin - 6                                  AA                        TT                                                                                                 [@b8], [@b46], [@b87]
  P10145                                         Interleukin - 8                                  AA                        TT                                                                                                 [@b8], [@b46], [@b87]
  P22301                                         Interleukin - 10                                 AA                      M, TT                                                                                                [@b8], [@b46], [@b87]
  Q9BY25                                         IL-1beta                                         AA                        TT                                                                                                 [@b8], [@b46], [@b87]
  P30740                                         Leukocyte elastase inhibitor                     MS                      M, MD                                                                                                        [@b85]
  P01834                                         Ig kappa chain C region                          MS                                              Yes                                                                                  [@b85]
  P01842                                         Ig lambda chain C regions                        MS                                              Yes                                                                                  [@b85]
  P31025                                         Lipocalin1 precursor                             MS                        TT                                                                                                         [@b85]
  P01871                                         Ig mu chain C region                             MS                                              Yes                                                                                  [@b85]
  P22079                                         Lactoperoxidase                                  MS                                              Yes                                                                                  [@b85]
  P05164                                         Myeloperoxidase                                  MS                                              Yes                                                                                  [@b85]
  P01833                                         Poly-IG receptor protein                         MS                        TT                                                                                                         [@b85]
  P12273                                         Prolactin-inducible protein                      MS                                              Yes                                                                                  [@b85]
  P26447                                         S100-A4                                          MS                        S                                                                                                          [@b17]
  P05109                                         S100-A8                                        MS, WB                    S, TT                   Yes                                                                              [@b18], [@b85]
  P06702                                         S100-A9                                          MS                        S                     Yes                                                                                  [@b17]
  P29508                                         Serpin B3                                        MS                      M, MD                   Yes                                                                              [@b14], [@b85]
  P42224                                         STAT-1                                         MS, AA                     S, M                                                                                                    [@b17], [@b80]
  P01135                                         Transforming growth factor alpha                 AA                        S                                                                                                      [@b8], [@b17]
  P01375                                         Tumor necrosis factor alpha                      AA                        TT                                                                                                     [@b8], [@b17]
  **Cytoskeleton Related Proteins**                                                                                                                                               
  P63151                                         Actin, cytoplasmic 2                             MS                       S, B                                                                                                [@b15], [@b16], [@b17]
  Q01518                                         Adenylyl cyclase                                 MS                        S                                                                                                          [@b17]
  P12830                                         Cadherin-1                                     MS, AA                    MD, TT                                                                                           [@b8], [@b15], [@b16], [@b17]
  P06731                                         Carcin-embryonic antigen                         MS                                              Yes                 Yes                                                              [@b85]
  P23528                                         Cofilin, non-muscle isoform                      MS                 S, B, M, MD, TT                                  Yes                                                          [@b14], [@b18]
  P15311                                         Ezrin                                            MS                       S, B                   Yes                 Yes                                                      [@b17], [@b80], [@b85]
  P06396                                         Gelsolin                                         MS                        S                     Yes                 Yes                                                      [@b17], [@b18], [@b85]
  P13646                                         Cytokeratin-13                                   MS                        S                                                                                                          [@b17]
  P08779                                         Cytokeratin-16                                   MS                                              Yes                                                                                  [@b85]
  P35527                                         Cytokeratin-9                                    MS                       S, B                                       Yes                                                              [@b15]
  P35908                                         Keratin, type II                                 MS                        S                                                                                                          [@b17]
  P04264                                         Cytokeratin 1                                    MS                     S, M, MD                 Yes                 Yes                                                              [@b17]
  P19013                                         Cytokeratin 4                                    MS                                              Yes                                                                                  [@b85]
  P13647                                         Cytokeratin-5                                    MS                        S                                                                                                          [@b28]
  P02538                                         Cytokeratin-6A                                   MS                                              Yes                                                                                  [@b80]
  P13645                                         Cytokeratin-10                                   MS                        S                                                                                                      [@b17], [@b87]
  P02533                                         Cytokeratin-14                                   MS                        TT                    Yes                                                                                  [@b85]
  P19012                                         Cytokeratin-15                                   MS                    M, MD, TT                 Yes                                                                                  [@b85]
  Q04695                                         Cytokeratin-17                                   MS                        TT                                                                                                         [@b45]
  P08727                                         Cytokeratin-19                                   MS                      S, TT                   Yes                                                                              [@b17], [@b87]
  P08729                                         Cytokeratin-7                                    MS                      S, TT                                                                                                [@b17], [@b80], [@b85]
  P26038                                         Moesin                                           MS                      M, MD                   Yes                 Yes                                                              [@b80]
  P07737                                         Profilin-1                                   MS, WB, E               S, B, M, MD, T              Yes                 Yes          [@b15], [@b16], [@b17], [@b18], [@b19], [@b20], [@b21], [@b22], [@b23], [@b24], [@b25], [@b26], [@b27], [@b85]
  P03749                                         Rho                                              AA                        S                                                                                                  [@b8], [@b15], [@b17]
  P31949                                         S100-A11                                         MS                        TT                    Yes                 Yes                                                              [@b85]
  P35321                                         Cornifin-A                                       MS                                              Yes                 Yes                                                              [@b85]
  P08670                                         Vimentin                                         MS                   S, B, M, MD                                    Yes                                                      [@b15], [@b16], [@b17]
  **Metabolism Related Proteins**                                                                                                                                                 
  P07108                                         AcylCoA binding protein                          AA                        B                                         Yes                                                          [@b15], [@b16]
  Q9DCT1                                         Aldo-keto reductase                              MS                        TT                                                                                                         [@b14]
  P06733                                         Alpha-enolase                                MS, WB, E              S, B, M, MD, TT              Yes                 Yes                                          [@b14], [@b15], [@b16], [@b17], [@b18], [@b85]
  P03973                                         Antileukoproteinase 1 precursor                  MS                                              Yes                                                                                  [@b85]
  P02647                                         Apolipoprotein A-I                               MS                      S, TT                   Yes                 Yes                                                          [@b15], [@b17]
  P02649                                         Apolipoprotein -E                                AA                                              Yes                                                                          [@b8], [@b15], [@b85]
  P06576                                         ATP synthase subunit beta                        MS                      M, MD                                                                                                        [@b80]
  P00915                                         Carbonic anhydrase 1                             MS                        TT                                        Yes                                                          [@b14], [@b18]
  P23280                                         Carbonic anhydrase 6                             MS                                              Yes                                                                                  [@b85]
  P07339                                         Cathepsin D                                  MS, AA, E                M, MD, T, S                                                                                             [@b8], [@b14], [@b17]
  P04080                                         Cystatin B                                       MS                        S                     Yes                                                                              [@b17], [@b85]
  P01034                                         Cystatin C                                       MS                        B                                                                                                          [@b16]
  P28325                                         Cystatin-D                                       MS                                              Yes                                                                                  [@b85]
  P01036                                         Cystatin-S precursor                             MS                                              Yes                                                                                  [@b85]
  P09228                                         Cystatin-SA precursor                            MS                                              Yes                                                                                  [@b85]
  P01037                                         Cystatin-SN precursor                            MS                                              Yes                                                                                  [@b85]
  Q01469                                         Fatty acid binding protein                       MS                      S, TT                   Yes                 Yes                                                      [@b8], [@b18], [@b85]
  P06744                                         Glucose-6-phosphate isomerase                    MS                     S, M, MD                                     Yes                                                          [@b14], [@b17]
  P09211                                         Glutathione S-transferase P                      MS                 S, B, M, MD, TT                                                                                   [@b14], [@b15], [@b16], [@b17], [@b18]
  P04075                                         Fructose biphosphate aldolase                    MS                      M, MD                                                                                                        [@b14]
  P40926                                         Malate dehydrogenase                             MS                   S, M, MD, T                                                                                                     [@b17]
  Q06830                                         Peroxiredoxin-1                                  MS                     S, B, TT                 Yes                                                                      [@b15], [@b16], [@b17], [@b85]
  P30041                                         Peroxiredoxin-6                                  MS                   B, M, MD, TT                                                                                           [@b14], [@b15], [@b16],
  P00558                                         Phosphoglycerate kinase 1                        MS                        S                     Yes                 Yes                                                          [@b17], [@b85]
  P14618                                         Pyruvate kinase PKM2                             AA                     B, M, MD                 Yes                                                                  [@b14], [@b15], [@b16], [@b18], [@b85]
  P10599                                         Thioredoxin                                      MS                     S, B, TT                 Yes                 Yes                                                  [@b15], [@b16], [@b17], [@b85]
  P37837                                         Transaldolase                                    MS                        S                                                                                                          [@b17]
  P29401                                         TranSetolase                                     MS                        S                                                                                                          [@b17]
  P60174                                         Triosephosphate isomerase                        MS                       B, M                                       Yes                                                      [@b14], [@b15], [@b16]
  P25311                                         Zinc-alpha-2-glycoprotein                   MS, 2DMS, E                  S, MC                   Yes                                                                                  [@b17]
  Q96DA0                                         Zymogen granule protein                          MS                                              Yes                                                                                  [@b85]
  **Membrane Related Proteins**                                                                                                                                                   
  P04083                                         Annexin A1                                       AA                 S, B, M, MD, TT              Yes                 Yes                                              [@b15], [@b16], [@b17], [@b74], [@b85]
  P46193                                         Annexin I                                      MS, WB                 S, B, M, MD                                                                                             [@b15], [@b16], [@b17]
  P07355                                         Annexin II                                     MS, WB               S, B, M, MD, TT              Yes                 Yes                                                  [@b14], [@b18], [@b74], [@b85]
  P12429                                         Annexin A3                                       MS                                              Yes                                                                              [@b14], [@b85]
  P15154                                         p21 Rac-1                                        AA                        S                                                                                                      [@b8], [@b17]
  P11233                                         Ras-related protein Ral-A                        AA                        TT                                                                                                     [@b8], [@b18]
  **Calcium Binding Related Proteins**                                                                                                                                            
  P62158                                         Calmodulin                                       MS                     B, M, MD                 Yes                 Yes                                                  [@b15], [@b16], [@b74], [@b85]
  P26447                                         S100-A4                                          MS                       S, B                                                                                                [@b15], [@b16], [@b17]
  P06703                                         S100-A6                                          MS                        S                     Yes                 Yes                                                      [@b17], [@b74], [@b85]
  P31151                                         S100-A7                                          MS                      S, TT                                                                                                    [@b16], [@b17]
  **Anti-Microbial Related Proteins**                                                                                                                                             
  P59666                                         Neutrophil defensin 3                            MS                                              Yes                                                                              [@b85], [@b87]
  P15515                                         Histatin-1 precursor                             MS                                              Yes                                                                                  [@b85]
  Q9HC84                                         Mucin-5B precursor                               MS                                              Yes                                                                                  [@b85]
  Q8TAX7                                         Mucin-7                                          MS                                              Yes                                                                                  [@b85]
  P02814                                         Submax. gland androgen-reg. prot.           MS, 2DMS, E                 S, M, MB                                                                                                      [@b17]
  P02788                                         Lactotransferrin                                 MS                                              Yes                                                                                  [@b85]
  P15941                                         Cancer antigen 15-3                              E                                               Yes                 Yes                                                          [@b29], [@b85]

Abbreviations: The UniProt identification number and protein name are from UniProt database ([www.uniprot.org](http://www.uniprot.org)). Method of Identification: MS = Mass spectrometry, 2DMS = 2D-Gel Spot Mass Spectrometry, E = ELISA, WB = Western blot, AA = Antibody Array. Cell Lines: S = SKBR3, M = MCF7, T = T47D, MD = MB-MDA-231, B = 8701-BC, TT = Tumor Tissue. Ref. = References.

###### Altered Salivary Proteins According to Molecular Function.

  Go Function                                Go ID       Gene Frequency & %
  --------------------------------------- ------------ -----------------------
  Anatomical Structure Development         GO:0048856   94 of 204 genes, 46%
  Biosynthetic Process                     GO:0009058   63 of 204 genes, 46%
  Carbohydrate Metabolic Process           GO:0005975   21 of 204 genes, 10%
  Catabolic Process                        GO:0009056   54 of 204 genes, 46%
  Cell Adhesion                            GO:0007155   26 of 204 genes, 13%
  Cell Cycle                               GO:0007049   22 of 204 genes, 11%
  Cell to Cell Signaling                   GO:0007267    19 of 204 genes, 9%
  Cell Death                               GO:0008219   65 of 204 genes, 46%
  Cell Differentiation                     GO:0030154   62 of 204 genes, 46%
  Cell Proliferation                       GO:0008283   50 of 204 genes, 25%
  Cellular Component Assembly              GO:0022607   45 of 204 genes, 22%
  Cellular Nitrogen Metabolic Process      GO:0034641   73 of 204 genes, 46%
  Cellular Protein Modification Process    GO:0006950   53 of 204 genes, 46%
  Chromosome Organization                  GO:0051276    14 of 204 genes, 7%
  Cytoskeleton                             GO:0007010   25 of 204 genes, 12%
  DNA Metabolic Process                    GO:0006259   27 of 204 genes, 13%
  Generation of metabolites & Energy       GO:0006091    14 of 204 genes, 7%
  Growth                                   GO:0040007   26 of 204 genes, 13%
  Homeostatic Process                      GO:0042592   53 of 204 genes, 46%
  Immune System                            GO:0002376   83 of 204 genes, 42%
  Lipid Metabolic Process                  GO:0006629   24 of 204 genes, 12%
  Membrane Organization                    GO:0061024    18 of 204 genes, 9%
  Morphogenesis                            GO:0006950   25 of 204 genes, 12%
  Response to Stress                       GO:0006950   107 of 204 genes, 52%
  Signal Transduction                      GO:0007165   86 of 204 genes, 46%
  Small Molecule Metabolic Process         GO:0044281   50 of 204 genes, 25%
  Transmembrane Transport                  GO:0055085    11 of 204 genes, 5%
  Transport                                GO:0006810   89 of 204 genes, 52%
  Vesicle-mediated Transport               GO:0016192   49 of 204 genes, 24%

###### National Cancer Institute's Pathway Interaction Database Analysis.

  Pathway                                                 Proteins                                                                                                                                                   p value
  ------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------- ----------
  [Signaling events mediated by HDAC Class III]{.ul}      CDKN1A, HIST1H4A, HIST1H4B, HIST1H4C, HIST1H4D, HIST1H4E, HIST1H4F, HIST1H4H, HIST1H4I, HIST1H4J, HIST1H4K, HIST1H4L, HIST2H4A, HIST2H4B, HIST4H4, TP53    6.22E-18
  [Glucocorticoid receptor regulatory network]{.ul}       AKT1, CDKN1A, IFNG, IL4, IL6, IL8, KRT14, KRT17, KRT5, SFN, STAT1, TP53                                                                                    6.73E-08
  [VEGFR1 specific signals]{.ul}                          AKT1, CALM1, CALM2, CALM3, NOS3, RASA1, VEGFA                                                                                                              1.52E-06
  [AP-1 transcription factor network]{.ul}                BAG1, CCL2, IFNG, IL10, IL4, IL6, IL8, MMP9, TP53                                                                                                          9.53E-06
  [Caspase Cascade in Apoptosis]{.ul}                     AKT1, APAF1, ARHGDIB, GSN, RIPK1, TNF, VIM, XIAP                                                                                                           1.43E-05
  [Insulin-mediated glucose transport]{.ul}               AKT1, CALM1, CALM2, CALM3, SFN, YWHAZ                                                                                                                      1.84E-05
  [SHP2 signaling]{.ul}                                   EGF, EGFR, IFNG, IL6, LCK, NOS3, STAT1, VEGFA                                                                                                              1.85E-05
  [a6b1 and a6b4 Integrin signaling]{.ul}                 AKT1, CDH1, EGF, EGFR, ERBB2, SFN, YWHAZ                                                                                                                   2.94E-05
  [Angiopoietin receptor Tie2-mediated signaling]{.ul}    AKT1, CDKN1A, FGF2, FYN, NOS3, RASA1, TNF                                                                                                                  4.45E-05
  [ErbB1 downstream signaling]{.ul}                       AKT1, CALM1, CALM2, CALM3, EGF, EGFR, RALA, SFN, STAT1, YWHAZ                                                                                              5.51E-05
  [IFN-gamma pathway]{.ul}                                AKT1, CALM1, CALM2, CALM3, IFNG, STAT1                                                                                                                     1.80E-04
  [ErbB receptor signaling network]{.ul}                  EGF, EGFR, ERBB2, TGFA                                                                                                                                     2.31E-04
  [HIF-1-alpha transcription factor network]{.ul}         AKT1, ALDOA, ENO1, PGK1, PKM, TF, VEGFA                                                                                                                    3.18E-04
  [Calcium signaling in the CD4+ TCR pathway]{.ul}        CALM1, CALM2, CALM3, IFNG, IL4                                                                                                                             3.20E-04
  [LKB1 signaling events]{.ul}                            CTSD, EZR, MAPT, SFN, TP53, YWHAZ                                                                                                                          3.29E-04
  [Ceramide signaling pathway]{.ul}                       AKT1, CTSD, EGF, EIF2AK2, RIPK1, TNF                                                                                                                       3.68E-04
  [Direct p53 effectors]{.ul}                             APAF1, CDKN1A, CTSD, EGFR, HSPA1A, HSPA1B, PCNA, SFN, TGFA, TP53                                                                                           3.82E-04
  [Signaling events mediated by PTP1B]{.ul}               AKT1, EGF, EGFR, FYN, LCK, TXN                                                                                                                             5.05E-04
  [Signaling events mediated by VEGFR1 and VEGFR2]{.ul}   AKT1, CALM1, CALM2, CALM3, FYN, NOS3, VEGFA                                                                                                                5.30E-04
  [EGF receptor (ErbB1) signaling pathway]{.ul}           EGF, EGFR, GSN, RASA1, STAT1                                                                                                                               5.66E-04
